+49 89 2872410
Professor Dr Andreas Martin Stark
Professor Dr Andreas Martin Stark

Professor Dr Andreas Martin Stark

Profession

Chief physician - Clinic for Neurosurgery and Spinal Surgery

Qualification

Specialist in Neurosurgery
Special Neurosurgical Oncology
Special Neurosurgical Intensive Care

CV

since 2023
Chief Physician, Neurosurgery and Spinal Surgery
Schön Kliniken Rendsburg und Eckernförde
2016 - 2023
Senior Consultant, Neurosurgery
Imland Kliniken Rendsburg und Eckernförde
2011 - 2011
Professorship
Klinik für Neurochirurgie, UKSH Campus Kiel
2008 - 2015
Senior Consultant
Klinik für Neurochirurgie, UKSH Campus Kiel
2006 - 2007
Consultant
Klinik für Neurochirurgie, UKSH Campus Kiel
2005 - 2005
Habilitation (Postdoctoral Qualification)
Klinik für Neurochirurgie, UKSH Campus Kiel
2002 - 2002
Research Fellowship
National Cancer Institute, National Institutes of Health, Bethesda, Maryland/USA
1999 - 2005
Specialist Training in Neurosurgery
Klinik für Neurochirurgie, UKSH Campus Kiel
1999 - 1999
Doctorate
1992 - 1999
Study of Human Medicine
Hamburg und Lübeck; Studienaufenthalte in Großbritannien, USA

Engagement

Membership
  • 2004 -

    German Society for Neurosurgery (DGNC)

  • 2002 -

    German Cancer Society (DKG)

  • 2012 -

    Association of Senior Hospital Physicians (VLK)

Publications

2015
Expression of DNA Mismatch Repair Proteins MLH1, MSH2 and MSH6 in Recurrent Glioblastoma

Stark AM, Doukas A, Hugo HH et al
Neurol Res, 37: 95-105

2013
Case report: Leptomeningeal metastasis of an intradural malignant peripheral nerve sheath tumor

Stark AM, Mehdorn HM
J Clin Neurosci 20: 1181-1183

2010
Surgical Treatment for Brain Metastases: Prognostic factors and survival in 309 patients with special regard to patient age

Stark AM, Stöhring C, Hedderich J, Held-Feindt J, Mehdorn HM
J Clin Neurosci, 18:34-38

2010
The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma

Stark AM, Doukas A, Hugo HH, Mehdorn HM
Neurol Res, 32: 816-820

2009
Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Up-regulation of Hexokinase 2 as a Correlate of Poor Prognosis

Palmieri D, Fitzgerald D, Stark AM
Mol Cancer Res, 7: 1438-1445

2009
Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status

Stark AM, Schem C, Maass N et al
Neurol Res, 23: 303-308

2008
Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype

Oxmann D, Held-Feindt J, Stark AM et al
Oncogene, 27:3567-75

2007
P53, BCL-2 and BAX in Non Small Cell Lung Cancer Brain Metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques.

Stark AM, Hugo HH, Tscheslog H, Mehdorn HM
Neurol Res 29:435-440

2007
Her-2 Overexpression Contributes to Breast Cancer Brain Metastasis

Palmieri D, Bronder JL, Stark AM et al
Cancer Research 67:4190-4198

2006
Case report: Chronic recurrent subarachnoid hemorrhage from a Trigeminal Nerve Malignant Peripheral Nerve Sheath Tumor

Stark AM, Buhl R, Straube T et al
Neurosurgery 59:E425

2005
Reduced mRNA and protein expression of Bcl-2 versus decreased mRNA and increased protein expression of BAX in Breast Cancer Brain Metastases: a real-time PCR and immunohistochemical evaluati

Stark AM, Fritsch MJ, Claviez A et al
Petriatr Neurol 33:33-38

2005

Stark AM, Tongers K, Maass N et al

2005
Case report: Malignant Peripheral Nerve Sheath Tumor and Growth Hormone producing Pituitary Adenoma

Stark AM, Mönig H, Mehdorn HM, Blömer U
The Endocrinologist 15:7-9

2004
Case report: Images in Neuro-Oncology: Dural Metastases

Stark AM, Mehdorn HM
J Neuro-Oncol 68:10

2003
Case report: Chondroid Clival Chordoma

Stark AM, Mehdorn HM
New Engl J Med 349:10